A Heightened Bar: Federal Circuit Leaves Functional Antibody Claims on Thin Ice

February 24, 2021

Amgen Faces “Uphill Battle” in Defending Antibody Genus Patentability

February 11, 2021

Big Pharma to Face Off at Federal Circuit Oral Arguments Over Antibody Genus Patentability

November 24, 2020

Federal Circuit Refuses to Reconsider Its Panel Decision Finding No Common Ownership of Immunex’s Enbrel Patents

October 6, 2020

Eli Lilly Files PGR Petition against Genentech’s IL-17A/F Heterodimer Patent

April 17, 2019

USPTO Celebrates Women in Innovation and Renames Auditorium in Honor of Clara Barton

March 6, 2019

FDA Issues New Guidance on Biosimilar Development under the BPCIA

January 11, 2019

Amendments on Amendments: USPTO Proposes Changes to the Motion to Amend Practice in AIA Trials

November 12, 2018

Third Time’s a Charm? Amgen Files Another BPCIA Lawsuit Against Apotex

August 30, 2018

Voluntary Dismissal Without Prejudice Does Not Nullify § 315(b)’s Time Bar

August 22, 2018